Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Immune responses against fibronectin modified by lipoprotein oxidation and their association with cardiovascular disease.

Dunér, Pontus LU ; To, Fong LU ; Alm, Ragnar LU ; Goncalves, Isabel LU orcid ; Nordin Fredrikson, Gunilla LU ; Hedblad, Bo LU ; Berglund, Göran LU ; Nilsson, J and Bengtsson, Eva LU orcid (2009) In Journal of Internal Medicine Feb 14.. p.593-603
Abstract
Abstract. Dunér P, To F, Alm R, Gonçalves I, Fredrikson GN, Hedblad B, Berglund G, Nilsson J, Bengtsson E (Malmö University Hospital, Lund University, Lund, Sweden). Immune responses against fibronectin modified by lipoprotein oxidation and their association with cardiovascular disease. J Intern Med 2009; doi: 10.1111/j.1365-2796.2008.02067.xObjectives. Accumulation and subsequent oxidation of LDL in the arterial wall are considered as key events in the development of atherosclerosis. We have investigated the possibility that LDL oxidation results in release of aldehydes that modify surrounding matrix proteins and that this may target immune responses against the plaque extracellular matrix and modulate the disease progression. Results.... (More)
Abstract. Dunér P, To F, Alm R, Gonçalves I, Fredrikson GN, Hedblad B, Berglund G, Nilsson J, Bengtsson E (Malmö University Hospital, Lund University, Lund, Sweden). Immune responses against fibronectin modified by lipoprotein oxidation and their association with cardiovascular disease. J Intern Med 2009; doi: 10.1111/j.1365-2796.2008.02067.xObjectives. Accumulation and subsequent oxidation of LDL in the arterial wall are considered as key events in the development of atherosclerosis. We have investigated the possibility that LDL oxidation results in release of aldehydes that modify surrounding matrix proteins and that this may target immune responses against the plaque extracellular matrix and modulate the disease progression. Results. Using custom-made ELISAs we demonstrate that human plasma contains autoantibodies against aldehyde-modified fibronectin (FN) and to a lesser extent also other extracellular matrix proteins including collagen type I, type III, and tenascin-C. Immunohistochemistry and western blot analysis showed that aldehyde-modified FN is present in human atherosclerotic plaques and that aldehydes generated by oxidation of LDL formed adducts with FN in vitro. We also demonstrate that aldehyde-modification of FN results in a loss of its ability to promote basal secretion of cytokines and growth factors from cultured macrophages without affecting the ability of the cells to respond to stimulation with LPS. A prospective clinical study demonstrated that subjects that subsequently developed acute myocardial infarction or sudden cardiac death had lower baseline levels of autoantibodies against aldehyde-modified FN than matched controls. Conclusions. These observations demonstrate that oxidation of LDL in the arterial wall may lead to aldehyde-modification of surrounding extracellular matrix proteins and that these modifications may affect macrophage function and activate autoimmune responses of pathophysiological importance for the development of atherosclerosis. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Journal of Internal Medicine
volume
Feb 14.
pages
593 - 603
publisher
Wiley-Blackwell
external identifiers
  • wos:000264959000008
  • pmid:19226376
  • scopus:64249130241
  • pmid:19226376
ISSN
1365-2796
DOI
10.1111/j.1365-2796.2008.02067.x
language
English
LU publication?
yes
id
59faac57-4e5e-4460-a323-153d2944102e (old id 1302447)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/19226376?dopt=Abstract
date added to LUP
2016-04-04 09:03:59
date last changed
2022-02-07 11:26:53
@article{59faac57-4e5e-4460-a323-153d2944102e,
  abstract     = {{Abstract. Dunér P, To F, Alm R, Gonçalves I, Fredrikson GN, Hedblad B, Berglund G, Nilsson J, Bengtsson E (Malmö University Hospital, Lund University, Lund, Sweden). Immune responses against fibronectin modified by lipoprotein oxidation and their association with cardiovascular disease. J Intern Med 2009; doi: 10.1111/j.1365-2796.2008.02067.xObjectives. Accumulation and subsequent oxidation of LDL in the arterial wall are considered as key events in the development of atherosclerosis. We have investigated the possibility that LDL oxidation results in release of aldehydes that modify surrounding matrix proteins and that this may target immune responses against the plaque extracellular matrix and modulate the disease progression. Results. Using custom-made ELISAs we demonstrate that human plasma contains autoantibodies against aldehyde-modified fibronectin (FN) and to a lesser extent also other extracellular matrix proteins including collagen type I, type III, and tenascin-C. Immunohistochemistry and western blot analysis showed that aldehyde-modified FN is present in human atherosclerotic plaques and that aldehydes generated by oxidation of LDL formed adducts with FN in vitro. We also demonstrate that aldehyde-modification of FN results in a loss of its ability to promote basal secretion of cytokines and growth factors from cultured macrophages without affecting the ability of the cells to respond to stimulation with LPS. A prospective clinical study demonstrated that subjects that subsequently developed acute myocardial infarction or sudden cardiac death had lower baseline levels of autoantibodies against aldehyde-modified FN than matched controls. Conclusions. These observations demonstrate that oxidation of LDL in the arterial wall may lead to aldehyde-modification of surrounding extracellular matrix proteins and that these modifications may affect macrophage function and activate autoimmune responses of pathophysiological importance for the development of atherosclerosis.}},
  author       = {{Dunér, Pontus and To, Fong and Alm, Ragnar and Goncalves, Isabel and Nordin Fredrikson, Gunilla and Hedblad, Bo and Berglund, Göran and Nilsson, J and Bengtsson, Eva}},
  issn         = {{1365-2796}},
  language     = {{eng}},
  pages        = {{593--603}},
  publisher    = {{Wiley-Blackwell}},
  series       = {{Journal of Internal Medicine}},
  title        = {{Immune responses against fibronectin modified by lipoprotein oxidation and their association with cardiovascular disease.}},
  url          = {{http://dx.doi.org/10.1111/j.1365-2796.2008.02067.x}},
  doi          = {{10.1111/j.1365-2796.2008.02067.x}},
  volume       = {{Feb 14.}},
  year         = {{2009}},
}